SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001232524-22-000021
Filing Date
2022-05-04
Accepted
2022-05-04 16:13:27
Documents
14
Period of Report
2022-05-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jazz-20220504.htm   iXBRL 8-K 37432
2 EX-99.1 a1q22financialpr.htm EX-99.1 456572
6 GRAPHIC jazzpharma_logoxfullcolor.jpg GRAPHIC 40079
  Complete submission text file 0001232524-22-000021.txt   733562

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jazz-20220504.xsd EX-101.SCH 1908
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jazz-20220504_lab.xml EX-101.LAB 25955
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jazz-20220504_pre.xml EX-101.PRE 13528
8 EXTRACTED XBRL INSTANCE DOCUMENT jazz-20220504_htm.xml XML 11739
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 22891656
SIC: 2834 Pharmaceutical Preparations